注冊以創建關於儀器的通知
你所追隨的作者的經濟活動和內容
免費註冊 已有帳戶? 登入
scPharmaceuticals Inc.是一家製藥公司。該公司專注於開發和商業化旨在降低醫療成本和改善健康結果的產品。該公司在內部和通過戰略合作夥伴關係開發產品和解決方案,旨在擴大和推進特定急性病症的門診護理。其主要候選產品FUROSCIX由其通過體內輸液器輸送的呋塞米配方組成,正在開髮用於治療充血性心力衰竭、肝硬化和腎病(包括腎病綜合徵)成人患者的水腫。其產品項目還包括scCeftriaxone和scCarbapenem。其scCeftriaxone是一種靜脈注射抗生素,用於治療由革蘭氏陽性和革蘭氏陰性微生物引起的感染。其scCarbapenem項目是一種靜脈注射抗生素,用於治療由革蘭氏陰性菌引起的感染。
名稱 | 年齡 | 成立於 | 主旨 |
---|---|---|---|
Jack A. Khattar | 63 | 2016 | Independent Chairman of the Board |
Klaus R. Veitinger | 62 | 2017 | Independent Director |
Dan Bensimhon | - | - | Member of Scientific Advisory Board |
William S. Weintraub | - | - | Member of Scientific Advisory Board |
William T. Abraham | 64 | 2021 | Independent Director |
Mette Kirstine Agger | 60 | 2014 | Independent Director |
Leonard D. Schaeffer | 78 | 2014 | Independent Director |
Marvin A. Konstam | - | - | Member of Scientific Advisory Board |
Frederick M. Hudson | 79 | 2018 | Independent Director |
John H. Tucker | 61 | 2016 | President, CEO, Principal Executive Officer & Director |
Sara M. Bonstein | 43 | 2020 | Independent Director |
Minnie V. Baylor-Henry | 76 | 2018 | Independent Director |
Stuart Russell | - | - | Member of Scientific Advisory Board |
G. Michael Felker | - | - | Member of Scientific Advisory Board |
William Franklin Peacock | - | - | Member of Scientific Advisory Board |
James E. Udelson | - | - | Member of Scientific Advisory Board |
你確定要封鎖 %USER_NAME%?
此舉將會令你與 %USER_NAME% 之間無法看見對方的Investing.com貼文。
%USER_NAME% 已成功加入你的封鎖清單
你剛解除此人的封鎖,必須等候 48 小時後才可再次封鎖。
我覺得這個評論是:
謝謝!
您的報告已被發送到我們的版主審核